Samda Biolab Co., Ltd. → Liminatus Pharma, Inc. LIMNW

Stake: — Shares: — Class: Common Stock , par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 1.06

3,511 shares short · -7.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $434

Point72 Asset Mgmt

Other 13D/G Filings on Liminatus Pharma, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-14	SCHEDULE 13D/A	Valetudo Therapeutics LLC	14.30%	9,617,954	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →